EUPATI has developed these guidance documents for all stakeholders aiming to interact with patients on medicines research and development (R&D). Users may deviate from this guidance according to specific circumstances, national legislation or the unique needs of each interaction. This guidance should be adapted for individual requirements using best professional judgment.

Owner (organization)

EUPATI

Target audience

Regulators, Health Technology Assessment (HTA) bodies, Other, Consumers

Types

Guidance

Formats

Online e-learning

Levels

Unknown

Language

English

Accessibility

Not applicable

Certification

No

Patients involved

No

PFMD last access

28 Nov 2020

Organizations